188 related articles for article (PubMed ID: 17208676)
1. MRI of the pancreas: tumours and tumour-simulating processes.
Schima W
Cancer Imaging; 2006 Dec; 6(1):199-203. PubMed ID: 17208676
[TBL] [Abstract][Full Text] [Related]
2. MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer.
Romijn MG; Stoker J; van Eijck CH; van Muiswinkel JM; Torres CG; Laméris JS
J Magn Reson Imaging; 2000 Aug; 12(2):261-8. PubMed ID: 10931589
[TBL] [Abstract][Full Text] [Related]
3. MR imaging of pancreatic disorders.
Outwater EK; Siegelman ES
Top Magn Reson Imaging; 1996 Oct; 8(5):265-89. PubMed ID: 8914226
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR imaging, CT, and cholangiography.
Low RN; Sigeti JS; Francis IR; Weinman D; Bower B; Shimakawa A; Foo TK
AJR Am J Roentgenol; 1994 Feb; 162(2):315-23. PubMed ID: 8310918
[TBL] [Abstract][Full Text] [Related]
5. Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions.
Boraschi P; Donati F; Gigoni R; Salemi S; Faggioni L; Del Chiaro M; Boggi U; Bartolozzi C; Falaschi F
Dig Liver Dis; 2009 Nov; 41(11):829-37. PubMed ID: 19303825
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
Schima W; Függer R; Schober E; Oettl C; Wamser P; Grabenwöger F; Ryan JM; Novacek G
AJR Am J Roentgenol; 2002 Sep; 179(3):717-24. PubMed ID: 12185052
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
Zanello A; Nicoletti R; Brambilla P; Boccuni R; Di Carlo V; Staudacher C; Del Maschio A
Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic adenocarcinoma: assessment of vascular invasion with high-field MR imaging and a phased-array coil.
Sironi S; De Cobelli F; Zerbi A; Angeli E; Balzano G; Taccagni G; Di Carlo V; Del Maschio A
AJR Am J Roentgenol; 1996 Oct; 167(4):997-1001. PubMed ID: 8819400
[TBL] [Abstract][Full Text] [Related]
9. State-of-the-art magnetic resonance imaging of pancreatic cancer.
Schima W; Ba-Ssalamah A; Goetzinger P; Scharitzer M; Koelblinger C
Top Magn Reson Imaging; 2007 Dec; 18(6):421-9. PubMed ID: 18303400
[TBL] [Abstract][Full Text] [Related]
10. [MRI of the pancreas: value of standard versus fat-suppressed pulse sequence at 0.5 T].
Müller-Miny H; Dülks A; Kreft B; Sommer T; Gieseke J; Görich J
Rofo; 1996 Jan; 164(1):19-24. PubMed ID: 8630355
[TBL] [Abstract][Full Text] [Related]
11. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
12. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
[TBL] [Abstract][Full Text] [Related]
13. [Combined use of MRI and MR cholangiopancreatography and contrast enhanced dual phase 3-D MR angiography in diagnosis of pancreatic tumors: initial clinical results].
Gaa J; Wendl K; Tesdal IK; Meier-Willersen HJ; Lehmann KJ; Böhm C; Möckel R; Richter A; Trede M; Georgi M
Rofo; 1999 Jun; 170(6):528-33. PubMed ID: 10420901
[TBL] [Abstract][Full Text] [Related]
14. Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI.
Kim JK; Altun E; Elias J; Pamuklar E; Rivero H; Semelka RC
J Magn Reson Imaging; 2007 Aug; 26(2):313-22. PubMed ID: 17610286
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of 2D and 3D MRI imaging in the diagnosis of pancreatic carcinoma].
Wang DQ; Zeng MS; Jin DY; Lou WH; Ji Y; Rao SX; Chen CZ; Li RC
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):216-20. PubMed ID: 17649641
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI in the characterization of cystic pancreatic lesions: usefulness of ADC values.
Boraschi P; Donati F; Gigoni R; Salemi S; Bartolozzi C; Falaschi F
Magn Reson Imaging; 2010 Dec; 28(10):1447-55. PubMed ID: 20864287
[TBL] [Abstract][Full Text] [Related]
17. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?
Coulam CH; Chan FP; Li KC
AJR Am J Roentgenol; 2002 Feb; 178(2):335-41. PubMed ID: 11804888
[TBL] [Abstract][Full Text] [Related]
18. MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT.
Rieber A; Tomczak R; Nüssle K; Klaus H; Brambs HJ
Br J Radiol; 2000 Nov; 73(875):1165-9. PubMed ID: 11144793
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of the pancreas.
Pamuklar E; Semelka RC
Magn Reson Imaging Clin N Am; 2005 May; 13(2):313-30. PubMed ID: 15935314
[TBL] [Abstract][Full Text] [Related]
20. MR-cholangiopancreaticography (MRCP) and MR-angiography: morphologic changes with magnetic resonance imaging.
Vahldiek G; Broemel T; Klapdor R
Anticancer Res; 1999; 19(4A):2451-8. PubMed ID: 10470174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
